India proposes mandatory CCTV at pharmacies for prescription-drug sales

The health ministry has proposed requiring medical stores to install CCTV coverage for sales of Schedule H, H1 and X medicines. Chemist body AIOCD estimates a ₹50,000–₹1 lakh-plus compliance burden for smaller outlets and flags deployment challenges in rural markets.

— Source publishedFri, 18 Sept, 2026, 14:01 IST·First seen Fri, 18 Sept, 2026, 14:24 IST·Source Business Today · Latest

What happened

India’s health ministry has proposed mandatory CCTV surveillance in medical stores for Schedule H, H1 and X drug sales. Pharmacy body AIOCD warns compliance could cost small chemists ₹50,000–₹1 lakh or more, with rural deployment challenges.

Key facts

  • 6 to 8 CCTV cameras
  • ₹50,000 to ₹1 lakh or more estimated compliance cost per small/medium chemist

Why this matters

Pharmacy platforms, surveillance vendors and health-tech firms may find partnership or acquisition opportunities in affordable CCTV, monitoring and compliance solutions tailored to small chemists.

What to watch

  • Publication of the final notification, including covered drug schedules, compliance deadline and penalties.
  • Whether rules specify video retention periods, remote monitoring, cloud storage, patient-privacy safeguards and camera-placement standards.
  • State drug-controller enforcement guidance and inspection protocols.
  • Any subsidy, tax deduction, low-cost financing or rural/small-store exemption framework.
  • AIOCD-led protests, litigation, negotiated revisions or implementation delays.
  • Changes in prescriptions, sales mix or availability of Schedule H, H1 and X medicines at independent stores.
  • M&A, franchising or procurement alliances involving independent chemists and organized pharmacy chains.
  • Pharmacy chains and hospital-linked dispensaries should audit camera coverage, data retention, power backup and internet connectivity at prescription counters.
  • Independent chemists should seek pooled procurement, leasing and standardized CCTV packages to lower upfront costs.
  • Retail pharmacy operators should model margin impact from installation, monitoring, maintenance, cybersecurity and potential staff requirements.
  • Drug distributors and pharmacies may shift more controlled-drug sales toward documented prescriptions and tighter inventory reconciliation.
  • Organized pharmacy chains may use compliance readiness in expansion pitches, franchise recruitment and enterprise partnerships.